trending Market Intelligence /marketintelligence/en/news-insights/trending/7six_hpkgk9vxwocx8wdng2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Orion Nutraceuticals to raise C$2M in nonbrokered private placement

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Orion Nutraceuticals to raise C$2M in nonbrokered private placement

Orion Nutraceuticals Inc. is looking to raise C$2 million in a nonbrokered private placement.

The Canadian cannabis company is offering 4 million units priced at 50 Canadian cents apiece.

Each unit will comprise 1 common share and 1 transferrable share purchase warrant. Each warrant will allow the holder to buy 1 additional common share for C$1 apiece within a 24-month period after the transaction's closing.

The private placement is subject to the approval of the Canadian Securities Exchange.

Orion will use the net proceeds for general working capital and corporate purposes.

Additionally, the company said in the news release that its common shares started trading on the CSE under the ORI symbol effective Oct. 17.

Vancouver, British Columbia-based Orion manufactures cannabis products with a focus on sports medicine, such as transdermal patches, topical gels and creams among others.